HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ettore Biagi Selected Research

Biological Products

9/2013Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ettore Biagi Research Topics

Disease

16Neoplasms (Cancer)
01/2020 - 01/2003
10Leukemia
01/2016 - 04/2003
10Graft vs Host Disease (Graft-Versus-Host Disease)
11/2015 - 11/2003
7B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 04/2003
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 12/2010
6Hematologic Neoplasms (Hematological Malignancy)
01/2017 - 03/2007
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2020 - 09/2006
2Neuroblastoma
11/2008 - 02/2007
1Disease Progression
01/2022
1Pathologic Complete Response
11/2020
1Bites and Stings (Sting)
01/2017
1Crohn Disease (Crohn's Disease)
04/2015
1Cardiomyopathies (Cardiomyopathy)
01/2015
1Chronic Renal Insufficiency
11/2013
1Proteinuria
11/2013
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
04/2009
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2009
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
04/2009
1Residual Neoplasm
11/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2006
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2006

Drug/Important Bio-Agent (IBA)

9Chimeric Antigen ReceptorsIBA
01/2022 - 03/2007
6CytokinesIBA
11/2020 - 09/2006
5VaccinesIBA
10/2011 - 04/2003
5CD40 Ligand (CD40L)IBA
10/2011 - 04/2003
5Interleukin-2 (IL2)IBA
10/2011 - 10/2005
4Monoclonal AntibodiesIBA
01/2017 - 03/2005
4AntigensIBA
01/2017 - 12/2006
4SteroidsIBA
04/2015 - 04/2009
2Biomarkers (Surrogate Marker)IBA
11/2013 - 11/2008
2ImmunosorbentsIBA
11/2008 - 02/2007
2Interferon-gamma (Interferon, gamma)IBA
11/2008 - 02/2006
2EnzymesIBA
11/2008 - 02/2007
2Interleukin-5 (Interleukin 5)IBA
11/2008 - 02/2006
2Proteins (Proteins, Gene)FDA Link
03/2007 - 04/2003
2Immunoglobulins (Immunoglobulin)IBA
12/2006 - 10/2005
2Neoplasm Antigens (Tumor Antigens)IBA
10/2005 - 04/2003
1Lenalidomide (CC 5013)FDA Link
01/2022
1Antigen Receptors (Antigen Receptor)IBA
11/2020
1CD19-specific chimeric antigen receptorIBA
01/2018
1Cancer VaccinesIBA
12/2017
1Surface Antigens (Surface Antigen)IBA
01/2017
1CD19 AntigensIBA
01/2017
1InterferonsIBA
04/2015
1Biological ProductsIBA
09/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2012
1Sialic Acid Binding Ig-like Lectin 3IBA
07/2011
1ChromiumIBA
12/2010
1Rituximab (Mabthera)FDA Link
04/2009
1InterleukinsIBA
11/2008
1lymphotactinIBA
02/2007
1CD20 AntigensIBA
12/2006
1Artificial ReceptorsIBA
12/2006
1Chemokine ReceptorsIBA
09/2006
1Granzymes (Granzyme)IBA
02/2006
1LigandsIBA
03/2005

Therapy/Procedure

16Immunotherapy
11/2020 - 04/2003
7Therapeutics
01/2017 - 01/2003
6Hematopoietic Stem Cell Transplantation
11/2020 - 11/2003
4Drug Therapy (Chemotherapy)
09/2013 - 02/2006
3Cell- and Tissue-Based Therapy (Cell Therapy)
11/2015 - 12/2010
3Stem Cell Transplantation
01/2012 - 02/2006
2Salvage Therapy
09/2010 - 07/2007
2Photopheresis
05/2009 - 07/2007
2Subcutaneous Injections
02/2007 - 02/2006
1Intravenous Administration
03/2014
1Plasmapheresis
11/2013
1Cell Transplantation
09/2010
1Extracorporeal Membrane Oxygenation
04/2009
1Radiotherapy
07/2007
1Transplantation
11/2003